- low risk entry at a good price- little chance of stag'ersbut your allocation will be small based on the amount offeredtherefore probably won't pay off unless you have the spare money- that was my reasoning
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025